Elucidation of the Mechanism of IL-22-Mediated Suppression of β-Cell Stress in Diabetes

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Pancreatic ?-cells produce the hormone insulin that controls blood sugar. Type 2 diabetes is characterized by inability of stressed ?-cells to make sufficient insulin to control blood sugar. We discovered that an immune factor, IL-22, protects ?-cells from stress. Treatment of diabetic mice with IL-22 resolves all the major problems in diabetes. This project seeks to reveal the mechanisms by which IL-22 protects ?-cells from stress, with potential for development of novel diabetes therapies.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $222,322.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cytokine signalling | gene expression | islets of Langerhans | oxidative stress | type 2 diabetes mellitus (non-insulin dependent diabetes mellitus)